Hiroyuki Yoshitsugu

BMS-911543, A Selective JAK2 Inhibitor: A Multicenter Phase 1/2a Study In Myelofibrosis

Animesh Pardanani, Andrew W. Roberts, John F. Seymour et al. · Blood · 2013 · 27 citations

Application of Physiologically Based Pharmacokinetic Modeling to Predict Pharmacokinetics in Healthy Japanese Subjects

Yuki Matsumoto, Tamara D. Cabalu, Punam Sandhu et al. · Clinical Pharmacology & Therapeutics · 2018 · 19 citations · Full text

A phase I, randomized, placebo‐controlled study of molnupiravir in healthy Japanese to support special approval in Japan to treat COVID‐19

Keisuke Nakamura, Katsukuni Fujimoto, Chihiro Hasegawa et al. · Clinical and Translational Science · 2022 · 15 citations · Full text

Pharmacokinetics, Safety, and Tolerability of Letermovir Following Single‐ and Multiple‐Dose Administration in Healthy Japanese Subjects

Kazuhiko Asari, Mikio Ishii, Hiroyuki Yoshitsugu et al. · Clinical Pharmacology in Drug Development · 2022 · 12 citations

Population pharmacokinetics of tazobactam/ceftolozane in Japanese patients with complicated urinary tract infection and complicated intra-abdominal infection

Makoto Kakara, Kajal Larson, Hwa-ping Feng et al. · Journal of Infection and Chemotherapy · 2018 · 11 citations · Full text

Normal Renal Function, Pharmacotherapy, Population Pharmacokinetics +21